---
$id: https://graph.org.ai/products/commodity/51172009
$type: Product
source: UNSPSC
code: "51172009"
title: "Clanobutin"
class: "51172000"
classTitle: "Drugs used for gallbladder disease"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Clanobutin

**UNSPSC Code**: 51172009
**Class**: [Drugs used for gallbladder disease](Drugs used for gallbladder disease.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cholagogue or choleretic agent with the molecular formula C18H18ClNO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W6Y945055S, chemically known as butyric acid, 4-(p-chloro-n-(p-methoxyphenyl)benzamido)- but generally known as clanobutin, which bears US NIH Compound Identifier 35378. European Medicines Agency schedules Clanobutin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06639MIG. The term CLANOBUTIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). CLANOBUTIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clanobutin under HS 29242995 and SITC 51479. As of Q4 2014, CLANOBUTIN remains the US FDA Preferred Term for this commodity. Clanobutin bears US NLM identifiers UMLS ID C0055854 and NCI Concept Code C77837. SMILES: CLC1CCC(C(=O)N(CCCC(=O)O)C2CCC(OC)CC2)CC1.

